Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor-Reference-Cited by-同舟云学术

Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor

Published:2017-03-17 Issue:8 Volume:19 Page:1079-1087
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Lee Young Eun,Choi Seung Ah,Kwack Pil Ae,Kim Hak Jae,Kim Il Han,Wang Kyu-Chang,Phi Ji Hoon,Lee Ji Yeoun,Chong Sangjoon,Park Sung-Hye,Park Kyung Duk,Hwang Do Won,Joo Kyeung Min,Kim Seung-Ki

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/8/1079/18768763/now300.pdf

Reference47 articles.

1. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study;Am J Surg Pathol,1998

2. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer;Nature,1998

3. INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma;J Neuropathol Exp Neurol,2005

4. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis;Lancet Oncol,2015

5. Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes;Cancer Cell,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/RTs);Radiotherapy and Oncology;2024-07

2. SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors;International Journal of Nanomedicine;2024-06

3. Ferroptosis: Frenemy of Radiotherapy;International Journal of Molecular Sciences;2024-03-25

4. Disulfiram: A novel repurposed drug for cancer therapy;Chinese Medical Journal;2024-01-26

5. Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review;Expert Opinion on Drug Delivery;2023-03-21